Addiction [NEW TOPIC PAGE]

Main|Search|PHGKB






Last Posted: Feb 08, 2018

---

• A brief review of the genetics and pharmacogenetics of opioid use disorders.  
  Berrettini Wade et al. Dialogues in clinical neuroscience 2017 Sep 19(3) 229-236
• Genome Culture: Genetic Testing for Susceptibility to Opioid Addiction Is a Risky Business  
  L Hercher, Genome Magazine, Jan 25, 2018
• GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA.  
  Blum Kenneth et al. Precision medicine 2017 2(1) 17-22
• The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction.  
  Zastrozhin Mikhail Sergeevich, et al. Pharmacogenomics and personalized medicine 2018 0 1-5
• Epigenetic regulation of the kappa opioid receptor gene by an insertion-deletion in the promoter region.  
  Lutz Pierre-Eric, et al. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2018 1
• Association between the Intron 8 VNTR Polymorphism of the DAT1 Gene and Crack Cocaine Addiction.  
  Stolf Anderson R, et al. Neuropsychobiology 2018 1 (3) 141-144

more